Policy | June 02, 2022
PMBI first time ever crossed Rs. 100 crore sales in May, 2022
Govt. has set a target to increase the number of JanAushadhi Kendras to 10,000 by March 2024
Govt. has set a target to increase the number of JanAushadhi Kendras to 10,000 by March 2024
RSV is the most common viral cause of respiratory tract infections in newborns, young children, older adults, or the immunocompromised
Researchers found that the drug combination led to a sustained and tenfold increase in the production of CD8 T cells and natural killer cells
Results from the DELIVER and DAPA-HF Phase III trials demonstrate Dapagliflozin’ efficacy in heart failure regardless of ejection fraction
The technology was able to identify approximately 32 percent more adenomas than standard colonoscopy procedures
The vaccine was found to have 64% efficacy against symptomatic disease and 92% against severe Covid-19
Globally, cervical cancer is the fourth most common cancer among women, with approximately 30,447 new cases diagnosed in Europe in 2020
Union Minister of State for Science and Technology, Dr Jitendra Singh gave the award for the successful commercialization of indigenous technology on National Technology Day 2022
Moderna continues to expand its mRNA platform for a range of additional clinical applications and routes of administration including a modality for lung delivery
Researchers presented these bladder cancer study findings at the 117th Annual Scientific Meeting of the American Urological Association (AUA)
Subscribe To Our Newsletter & Stay Updated
